Robert D Odze

Author PubWeight™ 133.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011 12.48
2 Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012 4.22
3 Transcolonic endoscopic cholecystectomy: a NOTES survival study in a porcine model (with video). Gastrointest Endosc 2006 3.32
4 Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol 2009 3.18
5 Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 2007 3.00
6 Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 2005 2.40
7 Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007 2.39
8 AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010 2.31
9 NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med 2007 2.23
10 AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010 2.09
11 Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol 2009 2.05
12 Definition of Barrett's esophagus: time for a rethink--is intestinal metaplasia dead? Am J Gastroenterol 2009 1.93
13 Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol 2002 1.79
14 EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc 2007 1.70
15 Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol 2003 1.66
16 Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med 2005 1.55
17 Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol 2011 1.50
18 Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study. Gastrointest Endosc 2007 1.47
19 Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol 2008 1.38
20 Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) 2013 1.31
21 Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol 2005 1.30
22 Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol 2002 1.30
23 Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol 2006 1.29
24 Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer 2007 1.26
25 Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol 2009 1.22
26 Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 2009 1.17
27 KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol 2010 1.15
28 Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol 2005 1.14
29 Neosquamous epithelium does not typically arise from Barrett's epithelium. Clin Cancer Res 2006 1.14
30 Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol 2009 1.14
31 Chromosomal instability in Barrett's esophagus is related to telomere shortening. Cancer Epidemiol Biomarkers Prev 2006 1.12
32 AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am J Surg Pathol 2006 1.09
33 Inflammatory fibroid polyps of the gastrointestinal tract: evidence for a dendritic cell origin. Am J Surg Pathol 2004 1.09
34 Liver disease in the patient with Fontan circulation. Congenit Heart Dis 2011 1.08
35 Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus. Hum Pathol 2006 1.08
36 The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PLoS One 2013 1.08
37 Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer 2002 1.07
38 Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors. Am J Surg Pathol 2002 1.05
39 Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol 2007 1.04
40 Fulminant hepatic failure secondary to erlotinib. Clin Gastroenterol Hepatol 2007 1.04
41 Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease. Am J Gastroenterol 2007 1.03
42 Utility of MMP-1, p53, E-cadherin, and collagen IV immunohistochemical stains in the differential diagnosis of adenomas with misplaced epithelium versus adenomas with invasive adenocarcinoma. Am J Surg Pathol 2002 1.02
43 Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 2009 1.02
44 Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases. Am J Surg Pathol 2007 1.01
45 Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol 2004 1.00
46 IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol 2010 0.98
47 NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet 2013 0.98
48 Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Cancer Epidemiol Biomarkers Prev 2006 0.98
49 Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study. Clin Cancer Res 2008 0.98
50 Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus. Am J Surg Pathol 2011 0.98
51 Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients. Histopathology 2011 0.97
52 Endoscopic mucosal tissue sampling. Gastrointest Endosc 2013 0.95
53 Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol 2005 0.95
54 Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol 2008 0.94
55 Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol 2007 0.94
56 Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2009 0.94
57 Neoplastic precursor lesions in Barrett's esophagus. Gastroenterol Clin North Am 2007 0.93
58 Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol 2006 0.93
59 Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol 2009 0.92
60 Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps. Hum Pathol 2002 0.91
61 Eosinophilic esophagitis without abundant eosinophils? The expanding spectrum of a disease that is difficult to define. Dig Dis Sci 2011 0.91
62 Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy. Am J Surg Pathol 2010 0.91
63 Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway. Hum Pathol 2009 0.91
64 MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6. Am J Surg Pathol 2011 0.91
65 Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus. Cancer Epidemiol Biomarkers Prev 2005 0.90
66 Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer 2008 0.89
67 Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis. Am J Surg Pathol 2013 0.89
68 Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007 0.89
69 Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma. Gastroenterol Clin North Am 2007 0.89
70 Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol 2004 0.89
71 DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett's esophagus and associated neoplastic lesions. Am J Surg Pathol 2008 0.88
72 Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol 2016 0.88
73 A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix. Am J Surg Pathol 2007 0.88
74 p16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One 2008 0.87
75 An unusual mixed tumor of the pancreas: sonographic and MDCT features. JOP 2009 0.86
76 Multilayered epithelium in mucosal biopsy specimens from the gastroesophageal junction region is a histologic marker of gastroesophageal reflux disease. Am J Surg Pathol 2009 0.85
77 Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. J Thorac Cardiovasc Surg 2004 0.85
78 The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis 2004 0.85
79 Clinical and pathological analysis of colonic Crohn's disease, including a subgroup with ulcerative colitis-like features. Mod Pathol 2011 0.85
80 The terminal ileum is affected in patients with lymphocytic or collagenous colitis. Am J Surg Pathol 2002 0.84
81 Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease. J Nucl Med 2010 0.84
82 Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps. Histopathology 2014 0.83
83 Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach. Am J Surg Pathol 2003 0.83
84 MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. Clin Transl Gastroenterol 2013 0.82
85 Low-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol 2006 0.82
86 Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma. Am J Surg Pathol 2006 0.82
87 Sequential clinical and histopathological changes in collagenous and lymphocytic colitis over time. Mod Pathol 2004 0.82
88 Predictors of Disease Recurrence and Survival in Esophageal Adenocarcinomas With Complete Response to Neoadjuvant Therapy. Am J Surg Pathol 2015 0.82
89 Management of neoplastic polyps in inflammatory bowel disease. Inflamm Bowel Dis 2003 0.82
90 Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study. Am J Surg Pathol 2009 0.82
91 Pathology of diseases that cause upper gastrointestinal tract bleeding. Gastrointest Endosc Clin N Am 2011 0.81
92 Acute hepatitis due to epstein-barr virus in an immunocompetent patient. Dig Dis Sci 2009 0.80
93 Pathologic features of reflux and Helicobacter pylori-associated carditis: a comparative study. Am J Surg Pathol 2003 0.80
94 Prospective Evaluation of Terminal Ileitis in a Surveillance Population of Patients with Ulcerative Colitis. Inflamm Bowel Dis 2016 0.80
95 Crypt dysplasia in Barrett's oesophagus shows clonal identity between crypt and surface cells. J Pathol 2013 0.79
96 Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol 2005 0.78
97 Vascular and lymphatic properties of the superficial and deep lamina propria in Barrett esophagus. Am J Surg Pathol 2008 0.78
98 MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction. Am J Surg Pathol 2011 0.78
99 Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus. Hum Pathol 2005 0.77
100 Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas. Am J Surg Pathol 2007 0.77
101 Prognostic significance of superficial fissuring ulceration in patients with severe "indeterminate" colitis. Am J Surg Pathol 2006 0.77
102 Cytokeratin 17: an adjunctive marker of invasion in squamous neoplastic lesions of the anus. Am J Surg Pathol 2014 0.77
103 Histologic Features Associated With Columnar-lined Esophagus in Distal Esophageal and Gastroesophageal Junction (GEJ) Biopsies From GERD Patients: A Community-based Population Study. Am J Surg Pathol 2016 0.76
104 Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer. Gastrointest Cancer Res 2009 0.76
105 Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study. Am J Surg Pathol 2016 0.76
106 Lymphocytic colitis secondary to ipilimumab treatment. Inflamm Bowel Dis 2013 0.76
107 Cell proliferation and differentiation in familial adenomatous polyposis. Hum Pathol 2004 0.75
108 Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis. Am J Surg Pathol 2008 0.75
109 Inflammatory fibroid polyps are not inflammatory myofibroblastic tumors. Diagn Cytopathol 2004 0.75
110 Significance of squamous metaplasia-like change in the esophagus. Am J Surg Pathol 2005 0.75
111 Reply. Inflamm Bowel Dis 2017 0.75
112 Adenocarcinoma complicating ulcerative colitis presenting as multiple pseudopolyp-like lesions. Clin Gastroenterol Hepatol 2011 0.75
113 Gastroesophageal junction hyperplastic (inflammatory) polyps: a clinical and pathologic study of 46 cases. Am J Surg Pathol 2011 0.75
114 Advanced precancerous lesions (APL) in the colonic mucosa. Best Pract Res Clin Gastroenterol 2013 0.75
115 "Mass-forming" variant of ischemic colitis is a distinct entity with predilection for the proximal colon. Am J Surg Pathol 2015 0.75
116 Morphological Features and Prognostic Significance of ARID1A-Deficient Esophageal Adenocarcinomas. Arch Pathol Lab Med 2017 0.75
117 Does rectal sparing ever occur in ulcerative colitis? Inflamm Bowel Dis 2008 0.75
118 Polypectomy is adequate treatment for adenoma-like dysplastic lesions (DALMs) in Crohn's disease. Inflamm Bowel Dis 2013 0.75